Excellent time to buy a multibagger !!

Zaktualizowano
Buy PW Medtech for 3x upside in the long term with strong fundamentals. Added spice is the technicals support with William %R being in the oversold category!!
Zlecenie aktywne
More BUY signals! CBPO 3Q results were mindblowing!: Company's key subsidiary CBPO has reported blockbuster 3Q results: Revenue and Operating earnings went up 14% YoY and 85% YoY, respectively. This will be reported on PW Medtech's Net profit on next earning season! On annual basis, this is around US37M annualized NP for PW Medtech. Company also made some sales of CBPO shares with total proceeds at US101mn so it's net cash would be US31M. Plus the company itself makes around US6MN in annual OP. So, let's just say we are only going to count CBPO value (14% stake in listed CBPO stock) & US31M in cash and giving 0 value to the parentco company.

CBPO's market cap is US4.4B and 13.9% of this equals 642m. This added with cash is US673m.Let's say we give around 30% discount on this value which is US436M. This is still 70% higher than current market price!!! Continue buying!
Chart PatternsTechnical IndicatorsTrend Analysis

Wyłączenie odpowiedzialności